Laman UtamaRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Tutup sebelumnya
CHF 2.37
Julat hari
CHF 2.38 - CHF 2.54
Julat tahun
CHF 1.06 - CHF 7.60
Permodalan pasaran
34.54J CHF
Bilangan Purata
19.00K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
SWX
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CHF) | Dis 2023info | Perubahan T/T |
|---|---|---|
Hasil | 1.50J | — |
Perbelanjaan pengendalian | 5.10J | — |
Pendapatan bersih | -20.84J | — |
Margin untung bersih | -1.38K | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -3.47J | — |
Kadar cukai berkesan | 12.33% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CHF) | Dis 2023info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 14.56J | — |
Jumlah aset | 76.39J | — |
Jumlah liabiliti | 24.16J | — |
Jumlah ekuiti | 52.23J | — |
Syer tertunggak | 12.54J | — |
Harga kepada buku | 0.57 | — |
Pulangan pada aset | -13.49% | — |
Pulangan pada modal | -18.23% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CHF) | Dis 2023info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -20.84J | — |
Tunai daripada operasi | -3.57J | — |
Tunai daripada pelaburan | 4.46J | — |
Tunai daripada pembiayaan | -62.00K | — |
Perubahan bersih dalam tunai | 882.00K | — |
Aliran tunai bebas | 2.79J | — |
Perihal
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Diasaskan
2013
Tapak web
Pekerja
36
